This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Europe

Poster Submission Deadline is April 7

  • 00
  • 00
  • 00
  • 00
Mark Your Calendar for BPI Europe 2023!
9-12 May 2023RAI in Amsterdam

Kumar Ashesh
CEO at Paras Biopharma


As CEO / Director of Biologics & Licensing at Paras Biopharma (Biologics CDMO) Finland, Dr Kumar is responsible for the organisation’s Biologics CDMO activities & capabilities, the company’s biologics development program, including development of Biosimilars (for Osteoporosis and Metabolic diseases). Prior to Paras Biopharma, Dr Kumar successfully developed & out-licensed biosimilar technologies for scale-up production of biologics & biosimilars in Europe & Asia. Dr Kumar was Head of Medipolis GMP Oy in Finland for 6 years and Head of the cGMP Biopharma team in Europe where he guided a team that successfully developed & licensed a key biosimilar technology for scale-up production in Europe.

Dr. Kumar attended Harvard Business School (USA), holds a management degree from JBIMS and MS & Ph.D. in Biosciences & Biotechnology from IIT - Roorkee, India.

Agenda Sessions

  • Panel Discussion: CGT CDMO Selection and Manufacturing Best Practices


Speakers at this event